Lannett Company, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 54   

Articles published

LCI 34.67 -1.18 (-3.29%)
price chart
Today's Dead Cat Bounce Stock Is Lannett Company (LCI)
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of branded pharmaceutical products in the United States.
Related articles »  
NYSE losers: Nationstar Mortgage Holdings Inc (NYSE:NSM), Lannett Company ...
Nationstar Mortgage Holdings Inc (NYSE:NSM) has named CFO David Hisey to the newly created post of chief strategy and external affairs officer.
Related articles »  
Lannett Company Lowered to �Neutral� at Zacks (LCI)
Lannett Company, Inc. logo Zacks lowered shares of Lannett Company (NYSE:LCI) from an outperform rating to a neutral rating in a research report released on Wednesday morning, AnalystRatingsNetwork.
Related articles »  
Zacks Downgrades Lannett Company to Neutral (LCI)
Lannett Company, Inc. logo Lannett Company (NYSE:LCI) was downgraded by Zacks from an �outperform� rating to a �neutral� rating in a research report issued on Wednesday, American Banking & Market News reports.
Related articles »  
Trader's Buzzers - Advanced Micro Devices, Inc. (AMD), Lannett Company, Inc ...
Lannett Company, Inc. (LCI) revealed that the company's president and chief executive officer, Arthur Bedrosian, chief financial officer, Martin Galvan, and chief operating officer, William Schreck, was presented at the 26thAnnual ROTH Conference on ...
Business Plans, Clinical Trial Results, Meetings, Conferences, and ...
Today, Analysts Review released its analysts' notes regarding Baxter International Inc. (NYSE:BAX) , Halozyme Therapeutics, Inc. (NASDAQ:HALO) , WellCare Health Plans, Inc. (NYSE:WCG) , PDL BioPharma, Inc. (NASDAQ:PDLI) , and Lannett Company, ...
Related articles »  
Lannett Receives FDA Approval for DiazepamOral Solution (Concentrate), 5 mg ...
PHILADELPHIA, Apr 15, 2014 (BUSINESS WIRE) -- Lannett Company, Inc. (NYSE:LCI) today announced that it has received approval from the U.S.
Lannett Says FDA OKs ANDA For Diazepam Oral Solution  NASDAQ
Related articles »  
Pre-market Equity Watch on the Health Care Sector -- Research on Isis Pharma ...
Investor-Edge has initiated coverage on the following equities: Isis Pharmaceuticals Inc. (NASDAQ:ISIS) , Pharmacyclics Inc. (UTC:PCYC) , Novo Nordisk A/S (NYSE:NVO) and Lannett Co. Inc. (NYSE:LCI) . Free technical research on ISIS, PCYC, NVO and ...
Drug Stocks to Watch: Pernix Therapeutics (NASDAQ:PTX), MEI Pharma ...
Lannett Company, Inc. logo Lannett Company (NYSE:LCI) was downgraded by Zacks from an �outperform� rating to a �neutral� rating in a research report issued on Wednesday, American Banking & Market News reports.
Related articles »  
Zebra Technologies (ZBRA) Numbers Signals, Lannett Company (LCI) FDA ...
Zebra Technologies (ZBRA) Numbers Signals, Lannett Company (LCI) FDA Green Light for Bioequivalent Diazepam Oral Solution. By riddock57.